CAPTRUST Financial Advisors’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $318K | Buy |
+11,542
| New | +$318K | ﹤0.01% | 2013 |
|
|
2024
Q4 | – | Sell |
-4,387
| Closed | -$293K | – | 2361 |
|
|
2024
Q3 | $293K | Sell |
4,387
-4,055
| -48% | -$271K | ﹤0.01% | 1889 |
|
|
2024
Q2 | $1M | Sell |
8,442
-40
| -0.5% | -$4.75K | ﹤0.01% | 1138 |
|
|
2024
Q1 | $904K | Sell |
8,482
-4,394
| -34% | -$468K | ﹤0.01% | 1183 |
|
|
2023
Q4 | $1.28M | Sell |
12,876
-99
| -0.8% | -$9.85K | ﹤0.01% | 1127 |
|
|
2023
Q3 | $1.34M | Buy |
12,975
+486
| +4% | +$50.2K | 0.01% | 1038 |
|
|
2023
Q2 | $1.52M | Sell |
12,489
-1,041
| -8% | -$126K | 0.01% | 953 |
|
|
2023
Q1 | $2.08M | Sell |
13,530
-4,401
| -25% | -$676K | 0.01% | 734 |
|
|
2022
Q4 | $3.22M | Buy |
17,931
+2,830
| +19% | +$508K | 0.02% | 565 |
|
|
2022
Q3 | $1.79M | Buy |
15,101
+4,158
| +38% | +$492K | 0.01% | 713 |
|
|
2022
Q2 | $1.56M | Buy |
10,943
+2,677
| +32% | +$382K | 0.01% | 673 |
|
|
2022
Q1 | $1.42M | Sell |
8,266
-427
| -5% | -$73.6K | 0.01% | 705 |
|
|
2021
Q4 | $2.21M | Sell |
8,693
-5,515
| -39% | -$1.4M | 0.02% | 540 |
|
|
2021
Q3 | $5.47M | Buy |
14,208
+837
| +6% | +$322K | 0.05% | 307 |
|
|
2021
Q2 | $3.14M | Buy |
13,371
+3,206
| +32% | +$753K | 0.03% | 384 |
|
|
2021
Q1 | $1.33M | Buy |
10,165
+1,168
| +13% | +$153K | 0.01% | 578 |
|
|
2020
Q4 | $940K | Buy |
8,997
+3,005
| +50% | +$314K | 0.01% | 626 |
|
|
2020
Q3 | $420K | Sell |
5,992
-11,344
| -65% | -$795K | 0.01% | 767 |
|
|
2020
Q2 | $1.07M | Sell |
17,336
-4,285
| -20% | -$264K | 0.02% | 485 |
|
|
2020
Q1 | $641K | Sell |
21,621
-272
| -1% | -$8.06K | 0.01% | 524 |
|
|
2019
Q4 | $421K | Buy |
+21,893
| New | +$421K | 0.01% | 738 |
|